Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra
- 14 August 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 329 (3) , 354-358
- https://doi.org/10.1016/s0304-3940(02)00704-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2001
- Inflammatory changes in the substantia nigra and striatum following MPTP intoxicationAnnals of Neurology, 2000
- Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In VivoJournal of Neurochemistry, 2000
- Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease developmentPublished by Elsevier ,1999
- Expression and Regulation of Cyclooxygenase‐2 in Rat MicrogliaEuropean Journal of Biochemistry, 1997
- The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependentBrain Research, 1996
- Glia-dependent neurotoxicity and neuroprotection in mesencephalic culturesBrain Research, 1995
- MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levelsSynapse, 1994
- MPTP-induced behavioural and biochemical deficits: A parametric analysisJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugsThe American Journal of Medicine, 1993